New research links inflammaging and immunosenescence to Alzheimer’s and Parkinson’s, with immune-modulating therapies showing early promise. Aging of the immune system accelerates brain di...
Recent studies reveal that immune aging, or ‘inflammaging,’ is a modifiable risk factor for neurodegenerative diseases, with new biomarkers and senolytic drugs offering hope for early inte...
A new study in Aging Cell uncovers a bidirectional feedback loop between intestinal aging and gut microbiome changes, accelerating systemic inflammation. A study in Aging Cell reveals how age-related ...
A 2025 study on Tibetan herders shows 30% higher inflammatory markers, contrasting with moderate altitude benefits. Implications for aging research and hypoxia-based therapies. High altitude may accel...
Phase 1 data for BGE-102 demonstrates significant reductions in hsCRP and inflammatory biomarkers, positioning it as a potential best-in-class therapy for cardiovascular risk and age-related inflammat...
New research shows that enzyme Pck1 depletion drives senescence in fat cells, causing insulin resistance and inflammaging, highlighting it as a promising target for age-related metabolic diseases. A r...
Recent studies reveal elevated IL-6 levels strongly correlate with Alzheimer’s and mild cognitive impairment, highlighting inflammaging’s role and potential for lifestyle and drug interven...
A 2023 study in ‘Aging Cell’ shows GDF3 drives inflammatory macrophage polarization in aging mice, linking it to metabolic decline and offering new therapeutic avenues for age-related dise...
